Clinical Trials Directory

Trials / Unknown

UnknownNCT00742066

Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

Insulin-induced Microvascular Activity in Patients With Essential Hypertension: a Possible Role for Angiotensin II AT1-receptor Blockers.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the insulin-induced microvascular dilatation. Objectives: 1. Does blockade of the angiotensin II AT1-receptor improve the insulin-induced microvascular effects in hypertensive patients. 2. Does blockade of the angiotensin II AT1-receptor impair the insulin-induced microvascular effects in normotensive control subjects?

Conditions

Interventions

TypeNameDescription
DRUGIrbesartanSingle dose 600mg orally
DRUGFelodipinesingle dose 10mg Felodipine ER
DRUGPlaceboSingle dose tablet orally

Timeline

Start date
2008-03-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2008-08-27
Last updated
2011-03-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00742066. Inclusion in this directory is not an endorsement.